Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Bárbara N. Porto & Theo J. Moraes. (2021) The triad: respiratory microbiome – virus – immune response in the pathophysiology of pulmonary viral infections. Expert Review of Respiratory Medicine 15:5, pages 635-648.
Read now
Read now
Haben Y Abraha, Krista L Lanctôt & Bosco Paes. (2015) Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention. Expert Review of Respiratory Medicine 9:6, pages 779-799.
Read now
Read now
J.M. Hussman, K.L. Lanctôt & B. Paes. (2013) The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence. Journal of Medical Economics 16:1, pages 115-124.
Read now
Read now
J Michael Hoopes & Veena R Kumar. (2012) Overview of respiratory syncytial virus disease in young children. Pediatric Health, Medicine and Therapeutics 3, pages 45-50.
Read now
Read now
Julia M Hussman, Abby Li, Bosco Paes & Krista L Lanctôt. (2012) A review of cost–effectiveness of palivizumab for respiratory syncytial virus. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 553-567.
Read now
Read now
Articles from other publishers (97)
Affan Shoukat, Elaheh Abdollahi, Alison P. Galvani, Scott A. Halperin, Joanne M. Langley & Seyed M. Moghadas. (2023) Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study. The Lancet Regional Health - Americas 28, pages 100629.
Crossref
Crossref
Alasdair P.S. Munro, Federico Martinón-Torres, Simon B. Drysdale & Saul N. Faust. (2023) The disease burden of respiratory syncytial virus in Infants. Current Opinion in Infectious Diseases.
Crossref
Crossref
Namrata Ahuja, Troy Richardson, Patrick Brady, Byron A. Foster, Justin Godown, Elise Lu, Nicolas Madsen, Samir S. Shah, Tamara Wagner, Susan Wu & Christopher Russell. (2023) Variation in Inhaled Medication Use for Infants With Congenital Heart Disease and Bronchiolitis. Hospital Pediatrics 13:8, pages 710-717.
Crossref
Crossref
Mary T. Caserta, Sean T. O’Leary, Flor M. Munoz, Shawn L. Ralston, Sean T. O’Leary, James D. Campbell, Monica I. Ardura, Ritu Banerjee, Kristina A. Bryant, Mary T. Caserta, Jeffrey S. Gerber, Chandy C. John, Athena P. Kourtis, Angela Myers, Pia Pannaraj, Adam J. Ratner, José R. Romero, Samir S. Shah, Kenneth M. Zangwill, Yvonne A. Maldonado, Flor M. Munoz, Shawn L. Ralston, David W. Kimberlin, Elizabeth D. Barnett, Ruth Lynfield, Mark H. Sawyer, Henry H. Bernstein, Karen M. Farizo, Lisa M. Kafer, David Kim, Eduardo López Medina, Denee Moore, Lakshmi Panagiotakopoulos, Laura Sauvé, Jeffrey R. Starke, Jennifer Thompson, Kay M. Tomashek, Melinda Wharton, Charles R. WoodsJr.Jr. & Jennifer M. Frantz. (2023) Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics.
Crossref
Crossref
Xin Cheng, Gan Zhao, Aihua Dong, Zhonghuai He, Jiarong Wang, Brian Jiang, Bo Wang, Miaomiao Wang, Xuefen Huai, Shijie Zhang, Shuangshuang Feng, Hong Qin & Bin Wang. (2023) A First-in-Human Trial to Evaluate the Safety and Immunogenicity of a G Protein-Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18–45 Years of Age. Vaccines 11:5, pages 999.
Crossref
Crossref
Sara Osman, Abdulqader Alaa adeen, Omar Hetta, Abdulaziz Alsiraihi, Mahmoud Bader, Alwaleed Aloufi, Amir Abushouk & Mohammed Yasir Al-hindi. (2023) Epidemiology and Risk Factor Analysis of Children with Bronchiolitis Admitted to the Intensive Care Unit at a Tertiary Care Center in Saudi Arabia. Children 10:4, pages 646.
Crossref
Crossref
Maria Ahuoiza Garba, Fatima Jummai Giwa, Hamdala Adelaiye, Abiola Aira Olorukooba, Fatima Abdullahi, Hauwa Makarfi, Yvette Löwensteyn, Louis Bont, Fadlullah Abdurraheem, Ehi Uudu, Halima Mudasir & Natalie I Mazur. (2023) Epidemiology of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection among Hospitalized Under-5s in Northwestern Nigeria. Journal of Pediatric Infectious Diseases 18:02, pages 101-106.
Crossref
Crossref
Amira D. Rghei, Jacob G. E. Yates, Jordyn A. Lopes, Xuiaoyan Zhan, Matthew M. Guilleman, Yanlong Pei, Laura P. van Lieshout, Lisa A. Santry, Byram W. Bridle, Khalil Karimi, Brad Thompson, Leonardo Susta, James E. CroweJr.Jr. & Sarah K. Wootton. (2023) Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis. Gene Therapy.
Crossref
Crossref
Wei Ji, Kan Zhang, Mengqi Li, Siyuan Wang, Liping Sun, Yue Huang, Jie Bai, Mazhong Zhang & Jijian Zheng. (2022) Do COVID-19 pandemic-related behavior changes affect perioperative respiratory adverse events in children undergoing cardiac interventional catheterization?. BMC Anesthesiology 22:1.
Crossref
Crossref
Marco Heppe-Montero, Stefan Walter, Valentín Hernández-Barrera, Ruth Gil-Prieto & Ángel Gil-de-Miguel. (2022) Burden of respiratory syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018. BMC Infectious Diseases 22:1.
Crossref
Crossref
Chaoyang Tong, Peiwen Liu, Kan Zhang, Ting Liu & Jijian Zheng. (2022) A novel nomogram for predicting respiratory adverse events during transport after interventional cardiac catheterization in children. Frontiers in Pediatrics 10.
Crossref
Crossref
Lise Beier Havdal, Håkon Bøås, Terese Bekkevold, Anne-Marte Bakken Kran, Astrid Elisabeth Rojahn, Ketil Størdal, Sara Debes, Henrik Døllner, Svein Arne Nordbø, Bjørn Barstad, Elisebet Haarr, Liliana Vázquez Fernández, Britt Nakstad, Christopher Inchley & Elmira Flem. (2022) Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age. Frontiers in Pediatrics 10.
Crossref
Crossref
Lauren C Bylsma, Mina Suh, Naimisha Movva, Jon P Fryzek & Christopher B Nelson. (2022) Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review. The Journal of Infectious Diseases 226:Supplement_2, pages S267-S281.
Crossref
Crossref
Ting Shi, Sophie Vennard, Sara Mahdy, Harish Nair, Harish Nair, Harry Campbell, Ting Shi, You Li, Peter Openshaw, Philippe Beutels, Louis Bont, Andrew Pollard, Eva Molero, Federico Martinon-Torres, Terho Heikkinen, Adam Meijer, Thea Kølsen Fischer, Maarten van den Berge, Carlo Giaquinto, Michael Abram, Kena Swanson, Sonia K Stoszek, Scott Gallichan, Clarisse Demont, Jeroen Aerssens, Arnaud Cheret, Brian Rosen & Robert Fuentes. (2022) Risk Factors for Poor Outcome or Death in Young Children With Respiratory Syncytial Virus–Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis. The Journal of Infectious Diseases 226:Supplement_1, pages S10-S16.
Crossref
Crossref
Julie A. Spencer, Deborah P. Shutt, S. Kane Moser, Hannah Clegg, Helen J. Wearing, Harshini Mukundan & Carrie A. Manore. (2022) Distinguishing viruses responsible for influenza-like illness. Journal of Theoretical Biology 545, pages 111145.
Crossref
Crossref
Jackelyn Murray, Harrison C. Bergeron, Les P. Jones, Zachary Beau Reener, David E. Martin, Fred D. Sancilio & Ralph A. Tripp. (2022) Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication. Viruses 14:5, pages 912.
Crossref
Crossref
Gemma L. Saravanos, Peter Hsu, David Isaacs, Kristine Macartney, Nicholas J. Wood & Philip N. Britton. (2021) Respiratory Syncytial Virus-attributable Deaths in a Major Pediatric Hospital in New South Wales, Australia, 1998–2018. Pediatric Infectious Disease Journal 41:3, pages 186-191.
Crossref
Crossref
Michael C. Spaeder, Claire Stewart, Matthew P. Sharron, Julia R. Noether, Natalia Martinez-Schlurman, Robert P. Kavanagh, Jessica K. Signoff, Michael C. McCrory, Daniel B. Eidman, Anjali V. Subbaswamy, Paul L. Shea, Ilana Harwayne-Gidansky, Emily K. Ninmer, Mary Lynn Sheram & Christopher M. Watson. (2020) Adenoviral Respiratory Infection-Associated Mortality in Children: A Retrospective Case Series. Journal of Pediatric Intensive Care 11:01, pages 013-018.
Crossref
Crossref
MW Lee & AEN Goh. (2021) Mortality in children hospitalised with respiratory syncytial virus infection in Singapore. Singapore Medical Journal 62:12, pages 642-646.
Crossref
Crossref
Luis Garegnani, Lea Styrmisdóttir, Pablo Roson Rodriguez, Camila Micaela Escobar Liquitay, Ignacio Esteban & Juan VA Franco. (2021) Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database of Systematic Reviews 2021:11.
Crossref
Crossref
Diego Rodríguez-Álvarez, Cristina Rodríguez-De Tembleque, Emilio Cendejas-Bueno, Elena Pérez-Costa, Jesús Díez-Sebastian & Pedro De la Oliva. (2021) Severity of bronchiolitis in infants is associated with their parents’ tobacco habit. European Journal of Pediatrics 180:8, pages 2563-2569.
Crossref
Crossref
Namrata Ahuja, Wendy J Mack, Susan Wu, John C Wood & Christopher J Russell. (2020) Acute respiratory infections in hospitalised infants with congenital heart disease. Cardiology in the Young 31:4, pages 547-555.
Crossref
Crossref
Mallavalli Surendranath. (2020) Respiratory Syncytial Virus. Pediatric Infectious Disease 2:4, pages 146-151.
Crossref
Crossref
Kathleen Chiotos, Molly Hayes, David W Kimberlin, Sarah B Jones, Scott H James, Swetha G Pinninti, April Yarbrough, Mark J Abzug, Christine E MacBrayne, Vijaya L Soma, Daniel E Dulek, Surabhi B Vora, Alpana Waghmare, Joshua Wolf, Rosemary Olivero, Steven Grapentine, Rachel L Wattier, Laura Bio, Shane J Cross, Nicholas O Dillman, Kevin J Downes, Carlos R Oliveira, Kathryn Timberlake, Jennifer Young, Rachel C Orscheln, Pranita D Tamma, Hayden T Schwenk, Philip Zachariah, Margaret L Aldrich, David L Goldman, Helen E Groves, Nipunie S Rajapakse, Gabriella S Lamb, Alison C Tribble, Adam L Hersh, Emily A Thorell, Mark R Denison, Adam J Ratner, Jason G Newland & Mari M Nakamura. (2021) Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. Journal of the Pediatric Infectious Diseases Society 10:1, pages 34-48.
Crossref
Crossref
Peter Paul RoeleveldAnneloes L. Van RijnRob B. P. de WildeErik W. van ZwetJeroen WinkLieke RozendaalKarin HogenbirkMark G. HazekampWing Ho ManIgor SidorovMargriet E. M. KraakmanEric C. J. ClaasEvert de JongeAloys C. M. KroesJutte J. C. de Vries. (2020) Rhinovirus Detection in the Nasopharynx of Children Undergoing Cardiac Surgery Is Not Associated With Longer PICU Length of Stay: Results of the Impact of Rhinovirus Infection After Cardiac Surgery in Kids (RISK) Study. Pediatric Critical Care Medicine 22:1, pages e79-e90.
Crossref
Crossref
Kathleen Chiotos, Molly Hayes, David W Kimberlin, Sarah B Jones, Scott H James, Swetha G Pinninti, April Yarbrough, Mark J Abzug, Christine E MacBrayne, Vijaya L Soma, Daniel E Dulek, Surabhi B Vora, Alpana Waghmare, Joshua Wolf, Rosemary Olivero, Steven Grapentine, Rachel L Wattier, Laura Bio, Shane J Cross, Nicholas O Dillman, Kevin J Downes, Kathryn Timberlake, Jennifer Young, Rachel C Orscheln, Pranita D Tamma, Hayden T Schwenk, Philip Zachariah, Margaret Aldrich, David L Goldman, Helen E Groves, Gabriella S Lamb, Alison C Tribble, Adam L Hersh, Emily A Thorell, Mark R Denison, Adam J Ratner, Jason G Newland & Mari M Nakamura. (2020) Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. Journal of the Pediatric Infectious Diseases Society 9:6, pages 701-715.
Crossref
Crossref
C. Efstathiou, S. H. Abidi, J. Harker & N. J. Stevenson. (2020) Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeutics. Cellular and Molecular Life Sciences 77:24, pages 5045-5058.
Crossref
Crossref
Wei Cai, Silke Buda, Ekkehard Schuler, Siddhivinayak Hirve, Wenqing Zhang & Walter Haas. (2020) Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes. Influenza and Other Respiratory Viruses 14:6, pages 658-670.
Crossref
Crossref
Luis Garegnani, Pablo Roson Rodriguez, Camila Micaela Escobar Liquitay, Ignacio Esteban & Juan VA Franco. (2020) Palivizumab for preventing respiratory syncytial virus (RSV) infection in children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Kan Zhang, Siyuan Wang, Mengqi Li, Chi Wu, Liping Sun, Sen Zhang, Jie Bai, Mazhong Zhang & Jijian Zheng. (2020) Anesthesia timing for children undergoing therapeutic cardiac catheterization after upper respiratory infection: a prospective observational study. Minerva Anestesiologica 86:8.
Crossref
Crossref
Xia LiXu WangShengli LiMin ZengDan Li. (2020) Viral Respiratory Infection, a Risk in Pediatric Cardiac Surgery: A Propensity-Matched Analysis*. Pediatric Critical Care Medicine 21:7, pages e431-e440.
Crossref
Crossref
Katie M. MoynihanTambra McGarveyAndrew BarlowClaire HeneyKristen GibbonsJulia E. ClarkSanmarié SchlebuschLuregn J. Schlapbach. (2020) Testing for Common Respiratory Viruses in Children Admitted to Pediatric Intensive Care: Epidemiology and Outcomes. Pediatric Critical Care Medicine 21:6, pages e333-e341.
Crossref
Crossref
Amanda J. Driscoll, S. Hasan Arshad, Louis Bont, Steven M. Brunwasser, Thomas Cherian, Janet A. Englund, Deshayne B. Fell, Laura L. Hammitt, Tina V. Hartert, Bruce L. Innis, Ruth A. Karron, Gayle E. Langley, E. Kim Mulholland, Patrick K. Munywoki, Harish Nair, Justin R. Ortiz, David A. Savitz, Nienke M. Scheltema, Eric A.F. Simões, Peter G. Smith, Fred Were, Heather J. Zar & Daniel R. Feikin. (2020) Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting. Vaccine 38:11, pages 2435-2448.
Crossref
Crossref
Sen Zhang, Ruidong Zhang, Meihua Cai, Kan Zhang, Mazhong Zhang & Jijian Zheng. (2020) Intranasal dexmedetomidine premedication in children with recent upper respiratory tract infection undergoing interventional cardiac catheterisation. European Journal of Anaesthesiology 37:2, pages 85-90.
Crossref
Crossref
August Wrotek, Małgorzata Kobiałka, Bartłomiej Grochowski, Iga Kamińska, Kaja Pędziwiatr, Anna Skoczek-Wojciechowska, Maria Godek & Teresa Jackowska. 2020. Health and Medicine. Health and Medicine
113
120
.
Jodi L. McGill, Sean M. Kelly, Mariana Guerra-Maupome, Emma Winkley, Jamie Henningson, Balaji Narasimhan & Randy E. Sacco. (2019) Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves. Scientific Reports 9:1.
Crossref
Crossref
Abhijeet R. Sonawane, Liang Tian, Chin-Yi Chu, Xing Qiu, Lu Wang, Jeanne Holden-Wiltse, Alex Grier, Steven R. Gill, Mary T. Caserta, Ann R. Falsey, David J. Topham, Edward E. Walsh, Thomas J. Mariani, Scott T. Weiss, Edwin K. Silverman, Kimberly Glass & Yang-Yu Liu. (2019) Microbiome-Transcriptome Interactions Related to Severity of Respiratory Syncytial Virus Infection. Scientific Reports 9:1.
Crossref
Crossref
Irina V. Davydova, L. S. Namazova-Baranova, M. V. Fedoseenko, K. A. Kazakova, N. E. Tkachenko & Yu. S. Akoev. (2019) IMMUNIZATION OF BRONCHOPULMONARY DYSPLASIA PATIENTS AGAINST RESPIRATORY PATHOGENS. Russian Pediatric Journal 20:4, pages 245-249.
Crossref
Crossref
Jodi L. McGill, Mariana Guerra-Maupome & Sarah Schneider. (2019) Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease. PLOS ONE 14:3, pages e0214407.
Crossref
Crossref
Bindongo Price Polycarpe Dembele, Taro Kamigaki, Clyde Dapat, Raita Tamaki, Mariko Saito, Mayuko Saito, Michiko Okamoto, Mary Ann U Igoy, Edelwisa Segubre Mercado, Melisa Mondoy, Veronica L Tallo, Socorro P Lupisan, Shinichi Egawa & Hitoshi Oshitani. (2019) Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study. BMJ Open 9:3, pages e026895.
Crossref
Crossref
Rachael Barr, Christopher A. Green, Charles J. Sande & Simon B. Drysdale. (2019) Respiratory syncytial virus: diagnosis, prevention and management. Therapeutic Advances in Infectious Disease 6, pages 204993611986579.
Crossref
Crossref
Jennifer Tam, Jesse Papenburg, Sergio Fanella, Sandra Asner, Michelle Barton, Cybele Bergeron, Shalini Desai, Charles Hui, Cheryl Foo, Joanne M Langley, Kirk Leifso, My-Linh Ma, Jeffrey Pernica, Joan Robinson, Roopi Singh, Bruce Tapiero & Upton Allen. (2019) Pediatric Investigators Collaborative Network on Infections in Canada Study of Respiratory Syncytial Virus–associated Deaths in Pediatric Patients in Canada, 2003–2013. Clinical Infectious Diseases 68:1, pages 113-119.
Crossref
Crossref
Marcelo C. Scotta, Paulo J.C. Marostica & Renato T. Stein. 2019. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
427
438.e4
.
Sebastien Kenmoe, Jean Joel Bigna, Estelle Amandine Well, Fredy Brice N. Simo, Véronique B. Penlap, Astrid Vabret & Richard Njouom. (2018) Prevalence of human respiratory syncytial virus infection in people with acute respiratory tract infections in Africa: A systematic review and meta-analysis. Influenza and Other Respiratory Viruses 12:6, pages 793-803.
Crossref
Crossref
Shobha Broor, Shama Parveen & Megha Maheshwari. (2018) Respiratory Syncytial Virus Infections in India: Epidemiology and Need for Vaccine. Indian Journal of Medical Microbiology 36:4, pages 458-464.
Crossref
Crossref
S. Zhang, S. Ding, M. Cai, J. Bai, M. Zhang, Y. Huang & J. Zheng. (2018) Impact of upper respiratory tract infections on perioperative outcomes of children undergoing therapeutic cardiac catheterisation. Acta Anaesthesiologica Scandinavica 62:7, pages 915-923.
Crossref
Crossref
Nienke M. Scheltema, Xynthia M. Kavelaars, Kentigern Thorburn, Marije P. Hennus, Job B. van Woensel, Cornelis K. van der Ent, José A.M. Borghans, Louis J. Bont & Julia Drylewicz. (2018) Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy. Vaccine 36:31, pages 4693-4700.
Crossref
Crossref
Elliott J. Carande, Eva P. Galiza, Alecia Nickless, Andrew J. Pollard & Simon B. Drysdale. (2018) Viral bronchiolitis management in hospitals in the UK. Journal of Clinical Virology 104, pages 29-33.
Crossref
Crossref
Demba Sarr, Eszter Tóth, Aaron Gingerich & Balázs Rada. (2018) Antimicrobial actions of dual oxidases and lactoperoxidase. Journal of Microbiology 56:6, pages 373-386.
Crossref
Crossref
L. S. Karpova, E. A. Smorodintseva, T. J. Sysoeva, T. P. Stolyarova, N. M. Popovtseva, K. A. Stolyarov, D. M. Danilenko & L. M. Tsybalova. (2018) The Spread of RS-virus Infection and other ARVI not Influenza Etiology in Children and Adults in the Regions of Russia from 2014 to 2016. Epidemiology and Vaccine Prevention 17:2, pages 16-26.
Crossref
Crossref
Nienke M Scheltema, Angela Gentile, Florencia Lucion, D James Nokes, Patrick K Munywoki, Shabir A Madhi, Michelle J Groome, Cheryl Cohen, Jocelyn Moyes, Kentigern Thorburn, Somsak Thamthitiwat, Hitoshi Oshitani, Socorro P Lupisan, Aubree Gordon, José F Sánchez, Katherine L O'Brien, Bradford D Gessner, Agustinus Sutanto, Asuncion Mejias, Octavio Ramilo, Najwa Khuri-Bulos, Natasha Halasa, Fernanda de-Paris, Márcia Rosane Pires, Michael C Spaeder, Bosco A Paes, Eric A F Simões, Ting F Leung, Maria Tereza da Costa Oliveira, Carla Cecília de Freitas Lázaro Emediato, Quique Bassat, Warwick Butt, Hsin Chi, Uzma Bashir Aamir, Asad Ali, Marilla G Lucero, Rodrigo A Fasce, Olga Lopez, Barbara A Rath, Fernando P Polack, Jesse Papenburg, Srđan Roglić, Hisato Ito, Edward A Goka, Diederick E Grobbee, Harish Nair & Louis J Bont. (2017) Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. The Lancet Global Health 5:10, pages e984-e991.
Crossref
Crossref
Dörthe Brüggmann, Corinna Köster, Doris Klingelhöfer, Jan Bauer, Daniela Ohlendorf, Matthias Bundschuh & David A Groneberg. (2017) Respiratory syncytial virus: a systematic scientometric analysis of the global publication output and the gender distribution of publishing authors. BMJ Open 7:7, pages e013615.
Crossref
Crossref
Hannah E. Gerretsen & Charles J. Sande. (2017) Development of respiratory syncytial virus (RSV) vaccines for infants. Journal of Infection 74, pages S143-S146.
Crossref
Crossref
Abby Li, Daniel Y. Wang, Krista L. Lanctôt, Ian Mitchell & Bosco A. Paes. (2017) Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005–2015). Pediatric Infectious Disease Journal 36:5, pages 445-450.
Crossref
Crossref
Katie Moynihan, Andrew BarlowNelson AlphonsoBen AndersonJanelle JohnsonClare Nourse, Sanmarié Schlebusch, Tom R. Karl & Luregn J. Schlapbach. (2017) Impact of Viral Respiratory Pathogens on Outcomes After Pediatric Cardiac Surgery. Pediatric Critical Care Medicine 18:3, pages 219-227.
Crossref
Crossref
Mitchell Goldstein, Raylene Philips, John DeVincenzo, Leonard Krilov, T. Allen Merritt, Ram Yogev, Suzanne Staebler, Munaf Kadri, Jaimie Fergie, Michael Schechter, Millicent Gorham & James Cherry. (2017) National Perinatal Association 2018 Respiratory Syncytial Virus (RSV) Prevention Clinical Practice Guideline: An Evidence-Based Interdisciplinary Collaboration. Neonatology Today 12:10, pages 1-14.
Crossref
Crossref
Robin J. Green, Heather J. Zar, Debbie A. White & Shabir A. Madhi. 2017. Viral Infections in Children, Volume II. Viral Infections in Children, Volume II
27
56
.
Robin J. Green & Jessica M. Kolberg. (2016) Neonatal pneumonia in sub-Saharan Africa. Pneumonia 8:1.
Crossref
Crossref
T. Ronan Leahy, Ross McManus, Derek G. Doherty, Robert Grealy, Michael J. Carr, Dubhfeasa Slattery & Thomas Ryan. (2016) Viral Bronchiolitis is Associated With Altered Cytokine Gene Expression and Lymphocyte Activation Status. Pediatric Infectious Disease Journal 35:11, pages e326-e338.
Crossref
Crossref
Koen B. Pouwels, Sefika E. Bozdemir, Selen Yegenoglu, Solmaz Celebi, E. David McIntosh, Serhat Unal, Maarten J. Postma & Mustafa Hacimustafaoglu. (2016) Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data. PLOS ONE 11:9, pages e0163567.
Crossref
Crossref
Shuenn-Nan Chiu, Pei-Lan Shao, Hui-Chi Chen, Ming-Tai Lin, Li-Min Huang, Feng-Yu Kao, San-Kuei Huang, Jou-Kou Wang & Mei-Hwan Wu. (2016) Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area. The Journal of Pediatrics 171, pages 25-30.e1.
Crossref
Crossref
Chaofan Li, Xian Zhou, Yiwei Zhong, Changgui Li, Aihua Dong, Zhonghuai He, Shuren Zhang & Bin Wang. (2016) A Recombinant G Protein Plus Cyclosporine A–Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease. The Journal of Immunology 196:4, pages 1721-1731.
Crossref
Crossref
Margaret Sheridan-Pereira, Joan Murphy, Julie Sloan, Gloria Crispino, Anne Leahy, J. David Corcoran, Eugene Dempsey, Basil Elnazir, Patrick Gavin, Farhana Sharif, Rizwan Gul, Salius Satas, John Murphy, Siobhan Gormally, Issam Shanaa, David Waldron, Paul Mc Mahon, John Carson, Maarten Blanken, Louis Bont & Bosco Paes. (2016) Respiratory Syncytial Virus Preterm (32–36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland. Pediatric Infectious Disease Journal 35:1, pages 19-24.
Crossref
Crossref
Ting Shi, Evelyn Balsells, Elizabeth Wastnedge, Rosalyn Singleton, Zeba A Rasmussen, Heather J Zar, Barbara A Rath, Shabir A Madhi, Stuart Campbell, Linda Cheyenne Vaccari, Lisa R Bulkow, Elizabeth D Thomas, Whitney Barnett, Christian Hoppe, Harry Campbell & Harish Nair. (2015) Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta–analysis. Journal of Global Health 5:2.
Crossref
Crossref
Lina Bollani, Eugenio Baraldi, Gaetano Chirico, Andrea Dotta, Marcello Lanari, Antonello Del Vecchio, Paolo Manzoni, Antonio Boldrini, Piermichele Paolillo, Sandra Di Fabio, Luigi Orfeo, Mauro Stronati & Costantino Romagnoli. (2015) Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV). Italian Journal of Pediatrics 41:1.
Crossref
Crossref
Katherine L O'Brien, Aruna Chandran, Robert Weatherholtz, Hasan S Jafri, M Pamela Griffin, Terramika Bellamy, Eugene V Millar, Kathryn M Jensen, Brian S Harris, Raymond Reid, Lawrence H Moulton, Genevieve A Losonsky, Ruth A Karron & Mathuram Santosham. (2015) Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. The Lancet Infectious Diseases 15:12, pages 1398-1408.
Crossref
Crossref
Jinghan Jenny Chen, Parco Chan, Bosco Paes, Ian Mitchell, Abby Li & Krista L. Lanctôt. (2015) Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention. PLOS ONE 10:8, pages e0134711.
Crossref
Crossref
Jeff Gobel, Margaret Gartland, Sarah Harris Gurley, Sue Kadwell, Dan Gillie, Chris Moore & Aaron Goetz. (2015) A Phenotypic High-Throughput Screen with RSV-Infected Primary Human Small Airway Epithelial Cells (SAECs). SLAS Discovery 20:6, pages 729-738.
Crossref
Crossref
Theophilus Adiku, Richard Asmah, Onike Rodrigues, Bamenla Goka, Evangeline Obodai, Andrew Adjei, Eric Donkor & George Armah. (2015) Aetiology of Acute Lower Respiratory Infections among Children Under Five Years in Accra, Ghana. Pathogens 4:1, pages 22-33.
Crossref
Crossref
Drew D Grosz, Albert van Geelen, Jack M Gallup, Shannon J Hostetter, Rachel J Derscheid & Mark R Ackermann. (2014) Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection. BMC Research Notes 7:1.
Crossref
Crossref
Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary Anne Jackson, Yvonne A. Maldonado, Dennis L. Murray, Walter A. Orenstein, Mobeen H. Rathore, Mark H. Sawyer, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis, Shawn L. Ralston, Allan S. Lieberthal, H. Cody Meissner, Brian K. Alverson, Jill E. Baley, Anne M. Gadomski, David W. Johnson, Michael J. Light, Nizar F. Maraqa, Eneida A. Mendonca, Kieran J. Phelan, Joseph J. Zorc, Danette Stanko-Lopp & Sinsi Hernández-Cancio. (2014) Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics 134:2, pages e620-e638.
Crossref
Crossref
Dorothy D. Gleditsch, Laurie P. Shornick, Juliette Van Steenwinckel, Pierre Gressens, Ryan P. Weisert & Joyce M. Koenig. (2014) Maternal inflammation modulates infant immune response patterns to viral lung challenge in a murine model. Pediatric Research 76:1, pages 33-40.
Crossref
Crossref
Michelle Butt, Amanda Symington, Marianne Janes, Susan Steele, LouAnn Elliott, Catherine Chant-Gambacort, Tapas Mondal & Bosco Paes. (2013) Respiratory syncytial virus prophylaxis in children with cardiac disease: a retrospective single-centre study. Cardiology in the Young 24:2, pages 337-343.
Crossref
Crossref
Rachel J. Derscheid, Albert van Geelen, Abigail R. Berkebile, Jack M. Gallup, Shannon J. Hostetter, Botond Banfi, Paul B. McCrayJr.Jr. & Mark R. Ackermann. (2014) Increased Concentration of Iodide in Airway Secretions Is Associated with Reduced Respiratory Syncytial Virus Disease Severity. American Journal of Respiratory Cell and Molecular Biology 50:2, pages 389-397.
Crossref
Crossref
M. R. Ackermann. (2014) Lamb Model of Respiratory Syncytial Virus-Associated Lung Disease: Insights to Pathogenesis and Novel Treatments. ILAR Journal 55:1, pages 4-15.
Crossref
Crossref
Rachel J. Derscheid, Jack M. Gallup, Cory J. Knudson, Steven M. Varga, Drew D. Grosz, Albert van Geelen, Shannon J. Hostetter & Mark R. Ackermann. (2013) Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV. PLoS ONE 8:12, pages e81472.
Crossref
Crossref
Silvia Ricart, Maria Angeles Marcos, Marta Sarda, Andres Anton, Carmen Muñoz‐Almagro, Tomas Pumarola, Marti Pons & Juan Jose Garcia‐Garcia. (2012) Clinical risk factors are more relevant than respiratory viruses in predicting bronchiolitis severity. Pediatric Pulmonology 48:5, pages 456-463.
Crossref
Crossref
Qingli Zhang, Zhongqin Guo, Zhenjiang Bai & Noni E. MacDonald. (2013) A 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China. Pediatric Pulmonology 48:4, pages 390-397.
Crossref
Crossref
Michael C. Spaeder, Jason W. Custer, Melania M. Bembea, Devon O. Aganga, Xiaoyan Song & Susanna Scafidi. (2013) A Multicenter Outcomes Analysis of Children With Severe Viral Respiratory Infection Due to Human Metapneumovirus. Pediatric Critical Care Medicine 14:3, pages 268-272.
Crossref
Crossref
Bosco Paes, Ian Mitchell, Abby Li, Tetsuhiro Harimoto & Krista L. Lanctôt. (2013) Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries. Clinical and Developmental Immunology 2013, pages 1-15.
Crossref
Crossref
Shelagh M. Szabo, Katherine L. Gooch, Meagan M. Bibby, Pamela G. Vo, Ian Mitchell, Pamela Bradt & Adrian R. Levy. (2013) The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection. Paediatric Respiratory Reviews 13, pages S1-S8.
Crossref
Crossref
Basil Elnazir, Oluwole Oni, Taha Hassan, Peter Greally & Bosco Paes. (2012) Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory-syncytial-virus-related infection in cystic fibrosis children less than 2 years of age?. Journal of Paediatrics and Child Health 48:11, pages 1033-1038.
Crossref
Crossref
Joseph A. Sykes, Rajiv Verma, Courtney Peshkovsky, Brian O’Connor, Farhan Malik, Joseph Lubega, Sunil Malhotra, Derrick McQueen, Susmita Mikkilineni & Meena Kalyanaraman. (2012) Early Repair of Large Infant Ventricular Septal Defect Despite Respiratory Syncytial Virus–Induced Respiratory Failure With Postrepair Chylous Pericardial Effusion Requiring Pleuropericardial Window. Pediatric Emergency Care 28:10, pages 1072-1077.
Crossref
Crossref
B. Paes, I. Mitchell, A. Li & K. L. Lanctôt. (2012) A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS). European Journal of Clinical Microbiology & Infectious Diseases 31:10, pages 2703-2711.
Crossref
Crossref
D. Che, J. Nicolau, J. Bergounioux, T. Perez & D. Bitar. (2012) Bronchiolite aiguë du nourrisson en France : bilan des cas hospitalisés en 2009 et facteurs de létalité. Archives de Pédiatrie 19:7, pages 700-706.
Crossref
Crossref
M. C. SPAEDER & J. C. FACKLER. (2011) A multi-tiered time-series modelling approach to forecasting respiratory syncytial virus incidence at the local level. Epidemiology and Infection 140:4, pages 602-607.
Crossref
Crossref
Bernhard Resch. (2012) Burden of respiratory syncytial virus infection in young children. World Journal of Clinical Pediatrics 1:3, pages 8.
Crossref
Crossref
Marianne Bracht, Debbie Basevitz, Marilyn Cranis, Rose Paulley & Bosco Paes. (2012) Identifying and Ensuring Optimal Care for All Children at Risk of Developing Serious Respiratory Syncytial Virus Disease: A Canadian Nurses’ Perspective. Neonatal Network 31:6, pages 369-386.
Crossref
Crossref
Marianne Bracht, Debbie Basevitz, Marilyn Cranis, Rose Paulley & Bosco Paes. (2012) Strategies for Reducing the Risk of Respiratory Syncytial Virus Infection in Infants and Young Children: A Canadian Nurses’ Perspective. Neonatal Network 31:6, pages 357-368.
Crossref
Crossref
Ieda Aparecida Correa Bueno, Adriana Gut Lopes Riccetto, André Moreno Morcillo, Clarice Weis Arns & Emílio Carlos Elias Baracat. (2012) Respiratory syncytial virus, infants and intensive therapy. The Brazilian Journal of Infectious Diseases 16:1, pages 86-89.
Crossref
Crossref
F. Gharabaghi, A. Hawan, S.J. Drews & S.E. Richardson. (2011) Evaluation of multiple commercial molecular and conventional diagnostic assays for the detection of respiratory viruses in children. Clinical Microbiology and Infection 17:12, pages 1900-1906.
Crossref
Crossref
Michael C. Spaeder & James C. Fackler. (2011) Hospital-acquired viral infection increases mortality in children with severe viral respiratory infection. Pediatric Critical Care Medicine 12:6, pages e317-e321.
Crossref
Crossref
Marianne Bracht, Debbie Basevitz, Marilyn Cranis & Rose Paulley. (2012) Impact of Respiratory Syncytial Virus. Drugs in R&D 11:3, pages 215-226.
Crossref
Crossref
Eliane Roseli Barreira, Alexander Roberto Precioso & Albert Bousso. (2010) Pulmonary surfactant in respiratory syncytial virus bronchiolitis: The role in pathogenesis and clinical implications. Pediatric Pulmonology 46:5, pages 415-420.
Crossref
Crossref
Bosco Paes & Paolo Manzoni. (2011) Special populations: Do we need evidence from randomized controlled trials to support the need for respiratory syncytial virus prophylaxis?. Early Human Development 87, pages S55-S58.
Crossref
Crossref
Nam Kyun KimJae Young Choi. (2011) Respiratory syncytial virus prevention in children with congenital heart disease: who and how?. Korean Journal of Pediatrics 54:5, pages 197.
Crossref
Crossref
Anna Lundin, Tomas Bergström, Loubna Bendrioua, Nina Kann, Beata Adamiak & Edward Trybala. (2010) Two novel fusion inhibitors of human respiratory syncytial virus. Antiviral Research 88:3, pages 317-324.
Crossref
Crossref